Thomas M. Loarie
Président chez REFOCUS GROUP, INC.
Postes actifs de Thomas M. Loarie
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REFOCUS GROUP, INC. | Président | 02/01/2014 | - |
| Directeur/Membre du Conseil | 01/01/2014 | - | |
Bryologyx, Inc.
 Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Directeur/Membre du Conseil | 01/12/2016 | - |
| Directeur Général | 01/12/2016 | - | |
| Fondateur | 01/12/2016 | - | |
Leap of Faith Technologies, Inc.
 Leap of Faith Technologies, Inc. Internet Software/ServicesTechnology Services Leap of Faith Technologies, Inc. provides e-health services to the healthcare and technology sectors. The private company is based in Crystal Lake, IL. | Président | - | - |
| Silicon Biodevices, Inc. | Président | - | - |
Historique de carrière de Thomas M. Loarie
Anciens postes connus de Thomas M. Loarie
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| American Hospital Supply Corp. | Corporate Officer/Principal | - | - |
| The Creighton University School of Medicine | Corporate Officer/Principal | - | - |
| The Graduate Theological Union | Directeur/Membre du Conseil | - | - |
| American Heyer-Schulte | Corporate Officer/Principal | - | 25/03/2010 |
| President | - | - | |
Keravision, Inc.
 Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Directeur Général | - | - |
| Président | - | - | |
| ░░░░░░░ ░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - | |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - | - |
| ░░░░░░░ | - | - | |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
| ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░░ | - | ░░░░░░░░░░ |
Formation de Thomas M. Loarie
| University of Notre Dame | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Statistiques
Internationale
| Etats-Unis | 18 |
| 2 |
Opérationnelle
| Corporate Officer/Principal | 6 |
| Chairman | 6 |
| Director/Board Member | 5 |
Sectorielle
| Health Technology | 7 |
| Consumer Services | 5 |
| Commercial Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REFOCUS GROUP, INC. | Commercial Services |
| Entreprise privées | 13 |
|---|---|
Mercator MedSystems, Inc.
 Mercator MedSystems, Inc. Medical SpecialtiesHealth Technology Mercator MedSystems, Inc. develops medical injection devices. The firm focuses on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. It offers bullfrog micro-infusion device and blowfish trans-bronchial micro-infusion device. The company was founded by Kirk Patrick Seward, Michael Vestel, and Albert P. Pisano in 2000 and is headquartered in Emeryville, CA. | Health Technology |
Uptake Medical Corp.
 Uptake Medical Corp. Medical SpecialtiesHealth Technology Uptake Medical Corp. develops medical technologies for the treatment of lung diseases. It provides InterVapor, an endoscopic lung volume reduction solution for people with severe emphysema that uses the body’s natural healing process without leaving implants or foreign materials in the lung; and InterVapor Personalized Procedure Program, a proprietary application that recommends treatment locations and ablation energy durations for each patient based on the patient’s CT scan. The company was founded by Robert L. Barry in 2004 and is headquartered in Tustin, CA. | Health Technology |
Novacor, Inc.
 Novacor, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Medtronic Plc, Novacor, Inc. is an American company that develops artificial heart and related technologies. The company is based in CA. Novacor was acquired by World Heart Corp., a subsidiary of Medtronic Plc from Edwards Lifesciences Corp. on June 30, 2000 for $58 million. | Commercial Services |
Advanced Medical Technology Association
 Advanced Medical Technology Association Miscellaneous Commercial ServicesCommercial Services Advanced Medical Technology Association is a trade association which provides medical technology solutions. The company was founded in 1974 and is headquartered in Washington, DC. | Commercial Services |
| California Healthcare Institute | Health Technology |
Clarity Medical Systems, Inc.
 Clarity Medical Systems, Inc. Electronic ComponentsElectronic Technology Clarity Medical Systems, Inc. developed, manufactured, and marketed integrated optical systems and services. Its products included Holos Intraop, Retcam3, Retcam Shuttle, and RCRS. The company was founded by Wei Su on February 13, 1991 and was headquartered in Pleasanton, CA. | Electronic Technology |
| CardioProfile, Inc. | |
| American Heyer-Schulte | |
Keravision, Inc.
Keravision, Inc. Medical SpecialtiesHealth Technology Keravision, Inc. was developed medical products for the treatment of common vision problems. The company was developed a new category of non-laser vision correction products for the treatment of common vision disorders, including myopia, hyperopia and astigmatism, to offer an alternative to eyeglasses, contact lenses and other vision correction surgical procedures. Its first product, Intacs corneal ring segments, based on its proprietary patented technology, has been approved by the FDA for correcting mild myopia. Intacs are the first surgical vision correction technology to be approved by the FDA for distribution and sales that is designed to permanently correct a patient's vision while providing the option of removability. Intacs are composed of two thin half-circles of polymer material that are inserted into the periphery of the cornea to reshape the curvature of the cornea to correct vision. | Health Technology |
| Silicon Biodevices, Inc. | |
Leap of Faith Technologies, Inc.
Leap of Faith Technologies, Inc. Internet Software/ServicesTechnology Services Leap of Faith Technologies, Inc. provides e-health services to the healthcare and technology sectors. The private company is based in Crystal Lake, IL. | Technology Services |
Bryologyx, Inc.
Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Health Technology |
| American Hospital Supply Corp. | Health Technology |
- Bourse
- Insiders
- Thomas M. Loarie
- Expérience